Ascendis Pharma AS
(NAS:ASND)
$
127.67
-0.7225 (-0.56%)
Market Cap: 7.63 Bil
Enterprise Value: 8.09 Bil
PE Ratio: 0
PB Ratio: 0
GF Score: 73/100 
Ascendis Pharma A/S Presents At Bank of America Securities 2021 Healthcare Conference (Virtual) Transcript
May 11, 2021 / 08:15PM GMT
Release Date Price:
$133.64
(+2.74%)
Tazeen Ahmad
BofA Securities, Research Division - VP
Good afternoon, everyone. Thanks for joining us back here at the Bank of America Healthcare Conference. It's my pleasure to have our next presenting company. Several members from the management team of the Ascendis are going to be chatting with me for the next 30 minutes. Unfortunately, they can see me, but I can't see them. So Jan and team, I'm going to turn it over to you guys to introduce yourselves. And then hopefully, we can just get into some Q&A, if that makes sense.
Jan Moller Mikkelsen;S;President
Ascendis Pharma A;CEO, Member of Executive Board & Executive Director
/- -
Thanks a lot, Tazeen. And I can start, Jan Mikkelsen, and then we have.
Scott T. Smith;S;CFO;Dana Pizzuti;S;SVP of Development Operations
Ascendis Pharma A;Senior VP & Member of Executive Board;Ascendis Pharma A
/- -
Scott Smith, CFO.
- /
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers